SpringerProtocols: Abstract: Nuclear Magnetic Resonance Metabonomics: Methods for Drug Discovery and Development

Nuclear Magnetic Resonance Metabonomics: Methods for Drug Discovery and Development

By: Karl-Heinz Ott², Nelly Aranibar²

Abstract

Full Text

Download PDF (757K)

Without Abstract

Affiliation(s): (2) Pharmaceutical Research Institute, Bristol-Myers Squibb, Princeton, NJ

Book Title: Metabolomics: Methods and Protocols

Series: Methods in Molecular Biology | Volume: 358 | Pub. Date: Sep-01-2006 | Page Range: 247-271 | DOI: 10.1007/978-1-59745-244-1_14

Subject: Bioinformatics

References

Download References

1.	Lindon, J. C., Holmes, E., and Nicholson, J. K. (2004) Toxicological applications of magnetic resonance. Prog. Nucl. Mag. Reson. Spectros. 45, 109–143.

2.	Colatsky, T. J. and Sumner, S. (2003) Metabolic profiling and biomarker discovery. Curr. Opin. Investig. Drugs 4, 262–263.

3.	Robertson, D. G. (2005) Metabonomics in toxicology: a review. Toxicol. Sci. 85, 809–822.

4.	Lindon, J. C., Holmes, E., Bollard, M. E., Stanley, E. G., and Nicholson, J. K. (2004) Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers 9, 1–31.

5.	Czuba, M. and Smith, I. C. (1991) Biological and NMR markers for cancer. Pharmacol. Ther. 50, 147–190. <Occurrence Type="DOI"><Handle>10.1016/0163-7258(91)90013-C</Handle></Occurrence>

6.	Odunsi, K., Wollman, R. M., Ambrosone, C. B., et al. (2005) Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics. Int. J. Cancer 113, 782–788.

7.	Griffiths, J. R. and Stubbs, M. (2003) Opportunities for studying cancer by metabolomics: preliminary observations on tumors deficient in hypoxia-inducible factor 1. Adv. Enzyme Regul. 43, 67–76. <Occurrence Type="DOI"><Handle>10.1016/S0065-2571(02)00030-4</Handle></Occurrence>

8.	Brindle, J. T., Antti, H., Holmes, E., et al. (2002) Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat. Med. 8, 1439–1444.

9.	Moolenaar, S. H., Engelke, U. F., and Wevers, R. A. (2003) Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism. Ann. Clin. Biochem. 40, 16–24.

10.	Bock, J. L. (1989) Nuclear magnetic resonance in the clinical laboratory. Am. J. Clin. Pathol. 91, S19–S26.

11.	Constantinou, M. A., Papakonstantinou, E., Spraul, M., et al. (2005) 1H NMRbased metabonomics for the diagnosis of inborn errors of metabolism in urine. Analytica Chimica Acta 542, 169–177.

12.	Constantinou, M. A., Papakonstantinou, E., Benaki, D., et al. (2004) Application of nuclear magnetic resonance spectroscopy combined with principal component analysis in detecting inborn errors of metabolism using blood spots: a metabonomic approach. Analytica Chimica Acta 511, 303–312.

13.	German, J. B., Roberts, M. A., and Watkins, S. M. (2003) Personal metabolomics as a next generation nutritional assessment. J. Nutr. 133, 4260–4266.

14.	Himmelreich, U., Somorjai, R. L., Dolenko, B., et al. (2003) Rapid identification of Candida species by using nuclear magnetic resonance spectroscopy and a statistical classification strategy. Appl. Environ. Microbiol. 69, 4566–4574.

15.	Fiehn, O., Kopka, J., Dormann, P., Altmann, T., Trethewey, R. N., and Willmitzer, L. (2000) Metabolite profiling for plant functional genomics. Nat. Biotechnol. 18, 1157–1161.

16.	Fiehn, O. (2002) Metabolomics: the link between genotypes and phenotypes. Plant Mol. Biol. 48, 155–171.

17.	Ott, K. H., Aranibar, N., Singh, B., and Stockton, G. W. (2003) Metabonomics classifies pathways affected by bioactive compounds. Artificial neural network classification of NMR spectra of plant extracts. Phytochemistry 62, 971–985. <Occurrence Type="DOI"><Handle>10.1016/S0031-9422(02)00717-3</Handle></Occurrence>

18.	Lindon, J. C., Nicholson, J. K., Holmes, E., et al. (2003) Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol. Appl. Pharmacol. 187, 137–146. <Occurrence Type="DOI"><Handle>10.1016/S0041-008X(02)00079-0</Handle></Occurrence>

19.	Holmes, E., Nicholson, J. K., Bonner, F. W., et al. (1992) Mapping the biochemical trajectory of nephrotoxicity by pattern recognition of NMR urinanalysis. NMR Biomed. 5, 368–372.

20.	Nicholson, J. K., Connelly, J., Lindon, J. C., and Holmes, E. (2002) Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 1, 153–161.

21.	Robertson, D. G., Reily, M. D., Sigler, R. E., Wells, D. F., Paterson, D. A., and Braden, T. K. (2000) Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. Toxicol. Sci. 57, 326–337.

22.	Bollard, M. E., Stanley, E. G., Lindon, J. C., Nicholson, J. K., and Holmes, E. (2005) NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed. 18, 143–162.

23.	Connor, S. C., Wu, W., Sweatman, B. C., et al. (2004) Effects of feeding and body weight loss on the 1H-NMR-based urine metabolic profiles of male Wistar Han rats: implications for biomarker discovery. Biomarkers 9, 156–179.

24.	Holmes, E., Foxall, P. J. D., Nicholson, J. K., et al. (1994) Automatic data reduction and pattern recognition methods for analysis of 1H nuclear magnetic resonance spectra of human urine from normal and pathological states. Anal. Biochem. 220, 284–296.

25.	Lindon, J. C., Holmes, E., and Nicholson, J. K. (2001) Pattern recognition methods and applications in biomedical magnetic resonance. Prog. Nucl. Magn. Reson. Spectros. 39, 1–40. <Occurrence Type="DOI"><Handle>10.1016/S0079-6565(00)00036-4</Handle></Occurrence>

26.	Eriksson, L., Antti, H., Gottfries, J., et al. (2004) Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm). Anal. Bioanal. Chem. 380, 419–29.

27.	Beckonert, O. E., Bollard, M., Ebbels, T. M. D., et al. (2003) NMR-based metabonomic toxicity classification: hierarchical cluster analysis and k-nearest-neighbour approaches. Analytica Chimica Acta 490, 3–15. <Occurrence Type="DOI"><Handle>10.1016/S0003-2670(03)00060-6</Handle></Occurrence>

28.	Aranibar, N., Singh, B. K., Stockton, G. W., and Ott, K. H. (2001) Automated mode-of-action detection by metabolic profiling. Biochem. Biophys. Res. Commun. 286, 150–155.

29.	Lenz, E. M., Bright, J., Wilson, I. D., et al. (2004) Metabonomics, dietary influences and cultural differences: a 1H NMR-based study of urine samples obtained from healthy British and Swedish subjects. J. Pharm. Biomed. Anal. 36, 841–849.

30.	Deprez, S., Sweatman, B. C., Connor, S. C., Haselden, J. N., and Waterfield, C. J. (2002) Optimisation of collection, storage and preparation of rat plasma for 1H NMR spectroscopic analysis in toxicology studies to determine inherent variation in biochemical profiles. J. Pharm. Biomed. Anal. 30, 1297–1310. <Occurrence Type="DOI"><Handle>10.1016/S0731-7085(02)00455-7</Handle></Occurrence>

31.	Araníbar, N., Ott, K.-H., Mueller, L., Contel, N., and Roongta, V. (2003) Experimental Nuclear Magenetic Resonance Conference, Savanna, GA. March 30–April 4, 2003.

32.	Araníbar, N., Ott, K.-H., Roongta, V., and Mueller, L. (2006) Anal. Biochem., in press.

33.	Keun, H. C., Ebbels, T. M. D., Antti, H., et al. (2003) Improved analysis of multivariate data by variable stability scaling: application to NMR-based metabolic profiling. Analytica Chimica Acta 490, 265–276. <Occurrence Type="DOI"><Handle>10.1016/S0003-2670(03)00094-1</Handle></Occurrence>

34.	Walczak, B. and Massart, D. L. (1995) Robust principal components regression as a detection tool for outliers. Chemometrics and Intelligent Laboratory Systems 27, 41–54. <Occurrence Type="DOI"><Handle>10.1016/0169-7439(94)00059-R</Handle></Occurrence>

35.	Kell, D. B. (2002) Metabolomics and machine learning: explanatory analysis of complex metabolome data using genetic programming to produce simple, robust rules. Mol. Biol. Rep. 29, 237–241.

Comments (Loading...)

Post comment/View all comments